Recent advances in pulmonary cytopathology.
During the past five years, advances in pulmonary cytopathology have made possible the achievement of several goals, including the diagnosis of pneumonias in immunocompromised hosts, the detection and localization of occult lung cancers in high-risk cigarette smokers, the diagnosis of lesions of the lungs and chest wall by fine-needle aspiration, and the detection of asbestos exposure by sputum cytologic studies. Significant progress has also been made in the application of cell image analysis to the detection of premalignant bronchial epithelial cells in sputum. For the most part, these advances are based on such well-known cytologic procedures as the preparation of thin and evenly distributed smears, prompt fixation, properly controlled and monitored Papanicolaou staining, and thorough screening of slides. Such diligence in laboratory techniques remains the backbone of excellence in pulmonary cytopathology. Cytologic findings should be interpreted with the clinical features of each case in mind, for the practice of pulmonary cytopathology remains an art as well as a science.
D001194:Asbestos / Q000009:adverse effects; D001707:Biopsy, Needle; D001999:Bronchoscopy; D002283:Carcinoma, Bronchogenic / Q000473:pathology; D003201:Computers; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000145:classification; D008171:Lung Diseases / Q000175:diagnosis / Q000473:pathology*; D008175:Lung Neoplasms / Q000473:pathology* / Q000556:secondary / Q000601:surgery; D008264:Macrophages / Q000166:cytology; D008297:Male; D008654:Mesothelioma / Q000473:pathology; D008679:Metaplasia / Q000473:pathology; D008875:Middle Aged; D010996:Pleural Effusion; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D011650:Pulmonary Alveoli / Q000166:cytology; D012907:Smoking; D013183:Sputum / Q000166:cytology
D001194:Asbestos